Terms: = Lymphoma AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
30 results:
1. Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma.
Yang M; Niu X; Yang X; Sun Y; Su W; Zhang J; Wu Q; Wang Y; Zhang Q; Ji H
Exp Biol Med (Maywood); 2023 Sep; 248(17):1469-1478. PubMed ID: 36847415
[TBL] [Abstract] [Full Text] [Related]
2. Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials.
Chihara D; Lin R; Flowers CR; Finnigan SR; Cordes LM; Fukuda Y; Huang EP; Rubinstein LV; Nastoupil LJ; Ivy SP; Doroshow JH; Takebe N
Lancet; 2022 Aug; 400(10351):512-521. PubMed ID: 35964611
[TBL] [Abstract] [Full Text] [Related]
3. Identification and therapeutic evaluation of ALK rearrangements in non-small-cell lung cancer.
Zhao R; Guo L; Zhang B; Zhao J; Xiang C; Chen S; Shao J; Zhu L; Ye M; Han Y
J Pathol Clin Res; 2022 Nov; 8(6):538-549. PubMed ID: 35848751
[TBL] [Abstract] [Full Text] [Related]
4. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Ishio T; Kumar S; Shimono J; Daenthanasanmak A; Dubois S; Lin Y; Bryant B; Petrus MN; Bachy E; Huang DW; Yang Y; Green PL; Hasegawa H; Maeda M; Goto H; Endo T; Yokota T; Hatanaka KC; Hatanaka Y; Tanaka S; Matsuno Y; Yang Y; Hashino S; Teshima T; Waldmann TA; Staudt LM; Nakagawa M
Blood; 2022 Mar; 139(10):1541-1556. PubMed ID: 34818414
[TBL] [Abstract] [Full Text] [Related]
5. Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study.
Jensen KS; Klug Albertsen B; Schrøder H; Zalounina Falborg A; Schmiegelow K; Rosthøj S; Callesen MT; Vedsted P
BMJ Open; 2021 Nov; 11(11):e049847. PubMed ID: 34810184
[TBL] [Abstract] [Full Text] [Related]
6. Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Orellana-Noia VM; Reed DR; McCook AA; Sen JM; Barlow CM; Malecek MK; Watkins M; Kahl BS; Spinner MA; Advani R; Voorhees TJ; Snow A; Grover NS; Ayers A; Romancik J; Liu Y; Huntington SF; Chavez JC; Saeed H; Lazaryan A; Raghunathan V; Spurgeon SE; Ollila TA; Del Prete C; Olszewski A; Ayers EC; Landsburg DJ; Echalier B; Lee J; Kamdar M; Caimi PF; Fu T; Liu J; David KA; Alharthy H; Law J; Karmali R; Shah H; Stephens DM; Major A; Rojek AE; Smith SM; Yellala A; Kallam A; Nakhoda S; Khan N; Sohail MA; Hill BT; Barrett-Campbell O; Lansigan F; Switchenko J; Cohen J; Portell CA
Blood; 2022 Jan; 139(3):413-423. PubMed ID: 34570876
[TBL] [Abstract] [Full Text] [Related]
7. Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements.
Eertink JJ; Arens AIJ; Huijbregts JE; Celik F; de Keizer B; Stroobants S; de Jong D; Wiegers SE; Zwezerijnen GJC; Burggraaff CN; Boellaard R; de Vet HCW; Hoekstra OS; Lugtenburg PJ; Chamuleau MED; Zijlstra JM;
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):943-952. PubMed ID: 34476551
[TBL] [Abstract] [Full Text] [Related]
8. Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study.
Camus V; Rossi C; Sesques P; Lequesne J; Tonnelet D; Haioun C; Durot E; Willaume A; Gauthier M; Moles-Moreau MP; Antier C; Lazarovici J; Monjanel H; Bernard S; Tardy M; Besson C; Lebras L; Choquet S; Le Du K; Bonnet C; Bailly S; Damaj G; Laribi K; Maisonneuve H; Houot R; Chauchet A; Jardin F; Traverse-Glehen A; Decazes P; Becker S; Berriolo-Riedinger A; Tilly H
Blood Adv; 2021 Oct; 5(19):3862-3872. PubMed ID: 34461634
[TBL] [Abstract] [Full Text] [Related]
9. Complications of intracerebroventricular chemotherapy via subgaleal reservoir in primary central nervous system lymphoma: A single-institution experience on 1247 installations in 94 consecutive patients.
Anton S; Margold M; Kowalski T; Miller D; Schmieder K; Schlegel U; Seidel S
Hematol Oncol; 2021 Apr; 39(2):176-184. PubMed ID: 33316084
[TBL] [Abstract] [Full Text] [Related]
10. Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on
Silvestri G; Trotta R; Stramucci L; Ellis JJ; Harb JG; Neviani P; Wang S; Eisfeld AK; Walker CJ; Zhang B; Srutova K; Gambacorti-Passerini C; Pineda G; Jamieson CHM; Stagno F; Vigneri P; Nteliopoulos G; May PC; Reid AG; Garzon R; Roy DC; Moutuou MM; Guimond M; Hokland P; Deininger MW; Fitzgerald G; Harman C; Dazzi F; Milojkovic D; Apperley JF; Marcucci G; Qi J; Polakova KM; Zou Y; Fan X; Baer MR; Calabretta B; Perrotti D
Blood Cancer Discov; 2020 Jul; 1(1):48-67. PubMed ID: 32974613
[TBL] [Abstract] [Full Text] [Related]
11. R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma.
Zhao F; Qin Y; Yang J; Liu P; He X; Zhou L; Zhou S; Gui L; Zhang H; Wang X; Jiang S; Zhong Q; Zhou Y; Shi Y
Asia Pac J Clin Oncol; 2020 Dec; 16(6):385-391. PubMed ID: 32779387
[TBL] [Abstract] [Full Text] [Related]
12. Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Brunstein CG; Pasquini MC; Kim S; Fei M; Adekola K; Ahmed I; Aljurf M; Agrawal V; Auletta JJ; Battiwalla M; Bejanyan N; Bubalo J; Cerny J; Chee L; Ciurea SO; Freytes C; Gadalla SM; Gale RP; Ganguly S; Hashmi SK; Hematti P; Hildebrandt G; Holmberg LA; Lahoud OB; Landau H; Lazarus HM; de Lima M; Mathews V; Maziarz R; Nishihori T; Norkin M; Olsson R; Reshef R; Rotz S; Savani B; Schouten HC; Seo S; Wirk BM; Yared J; Mineishi S; Rogosheske J; Perales MA
Biol Blood Marrow Transplant; 2019 Mar; 25(3):480-487. PubMed ID: 30423481
[TBL] [Abstract] [Full Text] [Related]
13. Recurrent
Matsuo H; Yoshida K; Fukumura K; Nakatani K; Noguchi Y; Takasaki S; Noura M; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Shiba N; Yamato G; Handa H; Ono Y; Hiramoto N; Ishikawa T; Usuki K; Ishiyama K; Miyawaki S; Itonaga H; Miyazaki Y; Kawamura M; Yamaguchi H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Hayashi Y; Mano H; Miyano S; Kamikubo Y; Ogawa S; Adachi S
Blood Adv; 2018 Nov; 2(21):2879-2889. PubMed ID: 30381403
[TBL] [Abstract] [Full Text] [Related]
14. Identification of Hub Genes and Key Pathways Associated with Two Subtypes of Diffuse Large B-Cell lymphoma Based on Gene Expression Profiling via Integrated Bioinformatics.
Liu Z; Meng J; Li X; Zhu F; Liu T; Wu G; Zhang L
Biomed Res Int; 2018; 2018():3574534. PubMed ID: 29992138
[TBL] [Abstract] [Full Text] [Related]
15. Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.
Chuang WY; Chang H; Chang GJ; Wang TH; Chang YS; Wang TH; Yeh CJ; Ueng SH; Chien HP; Chang CY; Wan YL; Hsueh C
Histopathology; 2017 May; 70(6):986-999. PubMed ID: 28032914
[TBL] [Abstract] [Full Text] [Related]
16. A Clinical and Economic Comparison of Rasburicase and Allopurinol in the treatment of Patients With Clinical or Laboratory Tumor Lysis Syndrome.
Cairo MS; Thompson S; Tangirala K; Eaddy MT
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):173-178. PubMed ID: 27965022
[TBL] [Abstract] [Full Text] [Related]
17. lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature.
Izquierdo C; Velasco R; Vidal N; Sánchez JJ; Argyriou AA; Besora S; Graus F; Bruna J
Neuro Oncol; 2016 May; 18(5):707-15. PubMed ID: 26415875
[TBL] [Abstract] [Full Text] [Related]
18. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract] [Full Text] [Related]
19. Inflammatory myofibroblastic tumours of the urinary bladder: multi-centre 18-year experience.
Teoh JY; Chan NH; Mak SM; Lo AW; Leung CY; Hui Y; Law IC; Fan CW; Cheung FK; Chan SW; Yiu MK; Man CW; So HS; Cheung HY; Hou SS; Ng CF
Urol Int; 2015; 94(1):31-6. PubMed ID: 25059529
[TBL] [Abstract] [Full Text] [Related]
20. Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma.
Ning H; Mitsui H; Wang CQ; Suárez-Fariñas M; Gonzalez J; Shah KR; Chen J; Coats I; Felsen D; Carucci JA; Krueger JG
Oncotarget; 2013 Dec; 4(12):2237-48. PubMed ID: 24163262
[TBL] [Abstract] [Full Text] [Related]
[Next]
